ENOCHIAN BIOSCIENCES INC(NASDAQ:ENOB) stock News

ENOB Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Benzinga - Mentions: MNK SDC CKPT APLS ...

12 Health Care Stocks Moving In Monday's Intraday Session

2 years ago - By: Benzinga - Mentions: DYNT NOVN TRIB ONCT ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

2 years ago - By: InvestorPlace - Mentions: ATRA PIRS AZN

3 Doomed Biotech Stocks Destined for Disaster

2 years ago - By: InvestorPlace - Mentions: HCTI CVKD ELOX FLJ ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

2 years ago - By: Enochian BioSciences, Inc.

Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting

2 years ago - By: Enochian BioSciences, Inc.

Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting

2 years ago - By: Enochian BioSciences, Inc.

Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review

2 years ago - By: Enochian BioSciences, Inc.

Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review

2 years ago - By: Enochian BioSciences, Inc.

Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher

2 years ago - By: Enochian BioSciences, Inc.

Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements

3 years ago - By: Seeking Alpha

Enochian gets Nasdaq listing deficiency notice for (NASDAQ:ENOB)

3 years ago - By: Seeking Alpha

Enochian gets Nasdaq notice for delaying (NASDAQ:ENOB)

3 years ago - By: Enochian BioSciences, Inc.

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022

3 years ago - By: Enochian BioSciences, Inc.

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K

3 years ago - By: Enochian BioSciences, Inc.

Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform

3 years ago - By: Bragar Eagel & Squire, P.C.

ENOCHIAN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Enochian Biosciences, Inc. and Encourages Investors to Contact the Firm

3 years ago - By: The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Enochian Biosciences, Inc. (ENOB)

3 years ago - By: Jakubowitz Law

ENOB SHAREHOLDER ALERT: Jakubowitz Law Reminds Enochian Shareholders of a Lead Plaintiff Deadline of September 26, 2022

3 years ago - By: Levi & Korsinsky, LLP

ENOB LAWSUIT ALERT: Levi & Korsinsky Notifies Enochian BioSciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

3 years ago - By: The Klein Law Firm

ENOB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 26, 2022 in the Class Action Filed on Behalf of Enochian BioSciences, Inc. Shareholders

3 years ago - By: The Law Offices of Vincent Wong

ENOCHIAN BIOSCIENCES INC (ENOB) Stock News

ENOB Latest News, Press Relases and Analysis

12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

3 Doomed Biotech Stocks Destined for Disaster

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting

Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting

Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review

Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review

Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher

Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements

Enochian gets Nasdaq listing deficiency notice for (NASDAQ:ENOB)

Enochian gets Nasdaq notice for delaying (NASDAQ:ENOB)

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K

Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform

ENOCHIAN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Enochian Biosciences, Inc. and Encourages Investors to Contact the Firm

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Enochian Biosciences, Inc. (ENOB)

ENOB SHAREHOLDER ALERT: Jakubowitz Law Reminds Enochian Shareholders of a Lead Plaintiff Deadline of September 26, 2022

ENOB LAWSUIT ALERT: Levi & Korsinsky Notifies Enochian BioSciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

ENOB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 26, 2022 in the Class Action Filed on Behalf of Enochian BioSciences, Inc. Shareholders

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Enochian Investors of a Lead Plaintiff Deadline of September 26, 2022